WallStreetZenWallStreetZen

NASDAQ: ATAI
Atai Life Sciences Nv Stock

$1.79+0.06 (+3.47%)
Updated Mar 27, 2024
ATAI Price
$1.79
Fair Value Price
$1.13
Market Cap
$297.16M
52 Week Low
$1.03
52 Week High
$2.39
P/E
-4.16x
P/B
1.12x
P/S
601.71x
PEG
N/A
Dividend Yield
N/A
Revenue
$334.00k
Earnings
-$66.94M
Gross Margin
100%
Operating Margin
-17,481.44%
Profit Margin
-20,043.1%
Debt to Equity
0.15
Operating Cash Flow
-$93M
Beta
1.39
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ATAI Overview

Atai Life Sciences N.V. is a clinical-stage biopharmaceutical company developing various therapeutic candidates that focus on various mental health disorders including depression, substance use disorder, and anxiety. The company's pipeline includes PCN-101, RL-007, DMX-1002, GRX-917, NN-101, VLS-01, EMP-01, RLS-01, DMX-1001, and others. Formerly known as Adripa Holding B.V., Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ATAI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ATAI ($1.79) is overvalued by 58.98% relative to our estimate of its Fair Value price of $1.13 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ATAI ($1.79) is not significantly undervalued (58.98%) relative to our estimate of its Fair Value price of $1.13 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ATAI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ATAI due diligence checks available for Premium users.

Be the first to know about important ATAI news, forecast changes, insider trades & much more!

ATAI News

Valuation

ATAI fair value

Fair Value of ATAI stock based on Discounted Cash Flow (DCF)
Price
$1.79
Fair Value
$1.13
Overvalued by
58.98%
ATAI ($1.79) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ATAI ($1.79) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ATAI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ATAI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.16x
Industry
14.3x
Market
44.45x

ATAI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.12x
Industry
6.2x
ATAI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ATAI's financial health

Profit margin

Revenue
$87.0k
Net Income
$44.2M
Profit Margin
50,855.2%
ATAI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ATAI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$308.2M
Liabilities
$39.7M
Debt to equity
0.15
ATAI's short-term assets ($215.83M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ATAI's short-term assets ($215.83M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ATAI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$18.4M
Investing
-$46.5M
Financing
$0.0
ATAI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ATAI vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ATAI$297.16M+3.47%-4.16x1.12x
PSTX$297.19M+9.61%-2.25x2.87x
VSTM$298.99M+1.98%-2.98x5.21x
FENC$295.25M+1.79%-14.59x-28.04x
ACIU$300.57M+6.69%-4.17x1.65x

Atai Life Sciences Nv Stock FAQ

What is Atai Life Sciences Nv's quote symbol?

(NASDAQ: ATAI) Atai Life Sciences Nv trades on the NASDAQ under the ticker symbol ATAI. Atai Life Sciences Nv stock quotes can also be displayed as NASDAQ: ATAI.

If you're new to stock investing, here's how to buy Atai Life Sciences Nv stock.

What is the 52 week high and low for Atai Life Sciences Nv (NASDAQ: ATAI)?

(NASDAQ: ATAI) Atai Life Sciences Nv's 52-week high was $2.39, and its 52-week low was $1.03. It is currently -25.1% from its 52-week high and 74.63% from its 52-week low.

How much is Atai Life Sciences Nv stock worth today?

(NASDAQ: ATAI) Atai Life Sciences Nv currently has 166,010,476 outstanding shares. With Atai Life Sciences Nv stock trading at $1.79 per share, the total value of Atai Life Sciences Nv stock (market capitalization) is $297.16M.

Atai Life Sciences Nv stock was originally listed at a price of $19.45 in Jun 18, 2021. If you had invested in Atai Life Sciences Nv stock at $19.45, your return over the last 2 years would have been -90.8%, for an annualized return of -69.66% (not including any dividends or dividend reinvestments).

How much is Atai Life Sciences Nv's stock price per share?

(NASDAQ: ATAI) Atai Life Sciences Nv stock price per share is $1.79 today (as of Mar 27, 2024).

What is Atai Life Sciences Nv's Market Cap?

(NASDAQ: ATAI) Atai Life Sciences Nv's market cap is $297.16M, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Atai Life Sciences Nv's market cap is calculated by multiplying ATAI's current stock price of $1.79 by ATAI's total outstanding shares of 166,010,476.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.